1. Home
  2. News
  3. Meetings and Workshops
  4. Advances in Biomedical Imaging, Bioengineering, and Related Technologies for the Development of Biomarkers of Pancreatic Disease
Banner for the 2015 Workshop on Advances in Biomedical Imaging, Bioengineering, and Related Technologies for the Development of Biomarkers of Pancreatic Disease

Advances in Biomedical Imaging, Bioengineering, and Related Technologies for the Development of Biomarkers of Pancreatic Disease

July 22, 2015 Location Contacts
Event Details Agenda

Event Details

Sponsored by

National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Biomedical Imaging and Bioengineering
The National Pancreas Foundation

Background

Benign and malignant pancreatic disease is frequently diagnosed at an advanced stage of disease due to the absence of accurate and sensitive biomarkers of early disease. Exocrine and endocrine insufficiency do not become apparent until the disease is advanced, due to the inherent functional reserve of the healthy pancreas. Conventional imaging methods are usually inadequate to confirm a diagnosis of early benign (e.g., chronic pancreatitis) or malignant (e.g., pancreatic ductal adenocarcinoma or PDAC) disease. As a result, there are no therapeutic agents available to reverse or prevent the progression of benign inflammation, and only 20 percent of patients with PDAC are candidates for curative therapy (of which more than half develop recurrent disease.)

Purpose

Recent advances in biomedical imaging, bioengineering, and related technologies offer new approaches to diagnosing the presence and stage of benign and malignant pancreatic diseases at an early time point in their course. The purpose of the planned workshop is to explore these advances to inform the community of clinician investigators who might want to evaluate these advances in clinical studies, and to inform the program officials at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and other agencies who are considering new initiatives for future funding opportunities.

Logistical Plan

The workshop will be designed as a 1-day workshop open to the public, and will be held at the University of Pittsburgh immediately prior to the start of the annual PancreasFest meeting on July 22, 2015. The workshop will consist of a number of invited expert speakers and moderators who will explore topics chosen by a multidisciplinary organizing committee. NIDDK will authorize an external meeting planning group, The Scientific Consulting Group, Inc. (SCG) of Gaithersburg, MD, to assist with the meeting logistics. Plans for the workshop, including topics, speaker selection and design of the workshop sessions, discussion of possible poster presentations, and engagement with other stakeholders will be the responsibility of the Organizing Committee.

Organizing Committee

Dana Andersen, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases

Randall Brand, M.D.
University of Pittsburgh

Teri Brentnall, M.D.
University of Washington

Tony Hollingsworth, M.D.
University of Nebraska

Marybeth Hughes, M.D.
National Cancer Institute

Kimberly Kelly, Ph.D.
University of Virginia

Christina Liu, Ph.D.
National Cancer Institute

Tony Sastre, Ph.D.
National Institute of Biomedical Imaging and Bioengineering

Jose Serrano, M.D., Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases

Sudhir Srivastava, M.D.
National Cancer Institute

David Whitcomb, M.D., Ph.D.
University of Pittsburgh